«12345...» Page 1 out of 6 last 30 days 14/02/2025 18:28 TALGO, S.A. (TALGO) On financial instruments Pegaso and a consortium of investors announce the agreement for the acquisition of approximately 29.7% of Talgo, at a fixed price of €4.15 and a variable price of up to €0.85 per share. Register number: 2605 14/02/2025 17:43 BANCO BILBAO VIZCAYA ARGENTARIA, S.A. On business and financial situation The Company informs about the dividend that its Board of Directors has resolved to propose to the Annual General Meeting of Shareholders. Register number: 2604 14/02/2025 08:59 TALGO, S.A. On corporate governance Resignation of Mr. Jose María Oriol as member of the board of Talgo SA Register number: 2603 14/02/2025 08:05 COCA-COLA EUROPACIFIC PARTNERS PLC On P&L Coca-Cola Europacific Partners plc publishes its preliminary unaudited results for the full year ended 31 December 2024 Register number: 2602 13/02/2025 14:25 OBRASCON HUARTE LAIN, S.A. On financial instruments The Company is pleased to inform that on the date hereof all transactions necessary to implement the Recapitalisation have been successfully completed and the Recapitalisation has become fully effective. Register number: 2601 11/02/2025 09:29 IBERCAJA BANCO, S.A. On buy-back offers for fixed-income instruments The Company reports of a cash repurchase offer to the holders of sub. notes to the issuance called "€500,000,000 Fixed Rate Reset Subordinated Notes due 23 July 2030", as well as the issue of sub. notes in the amount of 500 million € Register number: 2599 11/02/2025 09:05 TALGO, S.A. On corporate governance Resignation of propietary directors Register number: 2598 10/02/2025 22:47 HBX GROUP INTERNATIONAL PLC On share buy-back , stabilisation and treasury stock programmes BofA Securities Europe, S.A. informs about the commencement of start of Stabilisation Period Register number: 2597 10/02/2025 22:14 HBX GROUP INTERNATIONAL PLC On initial public offerings and public offerings for financial instruments The company announces the pricing of its initial public offering and the number of shares offered Register number: 2596 07/02/2025 07:36 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company reports on some of the results expected by the market consensus Register number: 2595 Page 1 out of 6 «12345...»